✦ LIBER ✦

Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia

✍ Scribed by Kristie A. Blum; Anjani Advani; Louis Fernandez; Richard Van Der Jagt; Joseph Brandwein; Suman Kambhampati; Jeannine Kassis; Melanie Davis; Claire Bonfils; Marja Dubay; Julie Dumouchel; Michel Drouin; David M. Lucas; Robert E. Martell; John C. Byrd

Book ID: 108676484
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 145 KB
Volume: 147
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2009.07881.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II clinical studies of denileukin

Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemia

✍ Arthur E. Frankel; Asha Surendranathan; Jennifer H. Black; Angela White; Kristen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB 👁 1 views

A phase I study of imatinib mesylate in

A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients

✍ Jonathan Hebb; Sarit Assouline; Caroline Rousseau; Pierre DesJardins; Stephen Ca 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 325 KB

A randomized phase II trial of fludarabi

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

✍ Peter Hillmen; Dena R. Cohen; Kim Cocks; Andrew Pettitt; Hazem A. Sayala; Andy C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

A pilot study of the Histone-Deacetylase

A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms

✍ Alessandro Rambaldi; Chiara Maria Dellacasa; Guido Finazzi; Alessandra Carobbio; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

Phase II study of the histone deacetylas

Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome

✍ Sophie Dimicoli; Elias Jabbour; Gautam Borthakur; Tapan Kadia; Zeev Estrov; Hui 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

Phase II study of subcutaneous alemtuzum

Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia

✍ Claes Karlsson; Jeanette Lundin; Eva Kimby; Ben Kennedy; Paul Moreton; Peter Hil 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB